STOCK TITAN

Berenberg Bank is now covering Biotage AB (publ) (BIOT)

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Biotage announced on June 29, 2021, that Berenberg Bank will begin coverage of the company through its Equity Research – Med Tech & Healthcare Services team. This development highlights Biotage's ongoing commitment to addressing societal challenges with innovative solutions across drug discovery, analytical testing, and environmental sustainability. With 2020 sales of 1,092 MSEK and a workforce of approximately 485 employees, Biotage operates globally, offering products in over 70 countries, and is listed on NASDAQ Stockholm under the ticker BIOT.

Positive
  • Berenberg Bank is now covering Biotage, potentially increasing investor interest.
  • Biotage reported 2020 sales of 1,092 MSEK, indicating solid revenue performance.
Negative
  • None.

UPPSALA, Sweden, June 29, 2021 /PRNewswire/ -- Biotage is proud to announce that Berenberg Bank now is covering Biotage through their Equity Research – Med Tech & HealthCare Services team.

This information was submitted for publication, through the agency of the contact persons set out above, at 11.00 CET on June 29, 2021


About Biotage
Biotage is a Global Impact Tech Company committed to solving society's problems. We offer workflow solutions and products to customers in drug discovery and development, analytical testing and water and environmental testing.

Biotage is contributing to sustainable science with the goal to make the world healthier, greener and cleaner – HumanKind Unlimited.

Our customers span a broad range of market segments including pharmaceutical, biotech, contract research and contract manufacturers as well as clinical, forensic and academic laboratories in addition to organizations focused on food safety, clean water and environmental sustainability.

Biotage is headquartered in Uppsala in Sweden and employs approx. 485 people worldwide. The Group had sales of 1,092 MSEK in 2020 and our products are sold in more than 70 countries. Biotage's share (BIOT) is listed in the Mid Cap segment on the NASDAQ Stockholm.
Website: www.biotage.com.

Contact persons:
Tomas Blomquist, CEO
Tel: 0705 23 01 63, tomas.blomquist@biotage.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/biotage/r/berenberg-bank-is-now-covering-biotage-ab--publ---biot-,c3376120

The following files are available for download:

https://mb.cision.com/Main/705/3376120/1438068.pdf

Press release (PDF)

Cision View original content:https://www.prnewswire.com/news-releases/berenberg-bank-is-now-covering-biotage-ab-publ-biot-301321713.html

SOURCE Biotage

FAQ

What does Berenberg Bank's coverage of Biotage mean for investors?

Berenberg Bank's coverage can enhance visibility and attract potential investors to Biotage.

When did Berenberg Bank start covering Biotage?

Berenberg Bank began covering Biotage on June 29, 2021.

What has been Biotage's sales figure for 2020?

Biotage reported sales of 1,092 MSEK for the year 2020.

In which markets does Biotage operate?

Biotage operates in pharmaceutical, biotech, and environmental testing markets globally.

Biotage Unsponso

OTC:BITGY

BITGY Rankings

BITGY Latest News

BITGY Stock Data

Testing Laboratories
Professional, Scientific, and Technical Services
Link
Sweden
Uppsala